Targeted radiation & immune boost: a new hope for esophageal cancer?
NCT ID NCT06676449
Summary
This study is testing if adding an immunotherapy drug to a new, more targeted form of radiation and standard chemotherapy works better for treating advanced esophageal cancer. Researchers will compare the new three-part combination to just the targeted radiation and chemotherapy to see which helps patients live longer without their cancer getting worse. The trial is for adults with a specific type of esophageal cancer that has not spread to distant organs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RADIOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.